Marshall Wace’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$156K	Sell	16,728 -11,030	-40%	-$96K	﹤0.01%	2829
2025 Q4	$208K	Sell	27,758 -118,149	-81%	-$1.2M	﹤0.01%	2583
2025 Q3	$1.27M	Sell	145,907 -111,713	-43%	-$668K	﹤0.01%	1835
2025 Q2	$956K	Buy	257,620 +99,332	+63%	+$349K	﹤0.01%	1874
2025 Q1	$511K	Buy	158,288 +105,544	+200%	+$497K	﹤0.01%	2070
2024 Q4	$294K	Sell	52,744 -112,449	-68%	-$882K	﹤0.01%	2240
2024 Q3	$1.79M	Sell	165,193 -20,673	-11%	-$343K	﹤0.01%	1412
2024 Q2	$3.9M	Sell	185,866 -71,880	-28%	-$1.8M	0.01%	1110
2024 Q1	$8.21M	Buy	+257,746	New	+$6.58M	0.01%	811
2023 Q2	–	Sell	-33,954	Closed	-$584K	–	2637
2023 Q1	$584K	Sell	33,954 -35,793	-51%	-$696K	﹤0.01%	2036
2022 Q4	$1.55M	Buy	+69,747	New	+$1.08M	﹤0.01%	1865
2022 Q1	–	Sell	-3,317	Closed	-$73K	–	3572
2021 Q4	$73K	Buy	+3,317	New	+$81.3K	﹤0.01%	3466
2021 Q2	–	Sell	-18,760	Closed	-$814K	–	2790
2021 Q1	$814K	Buy	18,760 +11,324	+152%	+$502K	﹤0.01%	1759
2020 Q4	$308K	Buy	+7,436	New	+$307K	﹤0.01%	1644